On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.

On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.